• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    10/9/25 4:28:32 PM ET
    $BFLY
    Medical Electronics
    Health Care
    Get the next $BFLY alert in real time by email
    bfly-20251005
    0001804176False00018041762025-10-052025-10-050001804176us-gaap:CommonStockMember2025-10-052025-10-050001804176us-gaap:WarrantMember2025-10-052025-10-05

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): October 5, 2025
    Butterfly Network, Inc.
    (Exact name of registrant as specified in its charter)
    Delaware001-3929284-4618156
    (State or other jurisdiction of
    incorporation)
    (Commission File Number)(IRS Employer
     Identification No.)
    1600 District Avenue
    Burlington, MA
    01803
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: (781) 557-4800
    Not applicable
    (Former name or former address, if changed since last report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Class A common stock, par value $0.0001 per shareBFLYThe New York Stock Exchange
    Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per shareBFLY WSThe New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company         ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
    On October 5, 2025, the board of directors of Butterfly Network, Inc. (the “Company”) appointed John Doherty to serve as Executive Vice President, Chief Financial Officer of the Company, effective December 8, 2025 (the “Effective Date”).
    John Doherty, 59, served as Chief Financial Officer of Kaltura, Inc. from March 2024 and will continue to serve in that role until his resignation effective December 5, 2025. Prior to that, Mr. Doherty served as Chief Financial and Operating Officer for Magic Leap, Inc., an augmented reality technology company, from 2020 to 2024, and as Chief Financial Officer of InterXion Holding N.V., a data center services provider, from 2018 to 2020. In addition, Mr. Doherty held a variety of financial roles at Verizon Communications Inc., over a 30-year period, most recently serving as Senior Vice President of Corporate Development and President & Chief Investment Officer of Verizon Ventures from 2013 to 2018, where he helped steer significant strategic transactions and corporate restructurings. Mr. Doherty currently also serves on the Board of Directors of Guam-based Pacific Telecom, Inc. Mr. Doherty holds a degree in economics from Stony Brook University and has attended the MBA program at Baruch College as well as Wharton’s Executive Education program in Finance and Strategic Planning.
    There are no family relationships between Mr. Doherty and any Company director or executive officer, and no arrangements or understandings between Mr. Doherty and any other person pursuant to which he was selected as Executive Vice President, Chief Financial Officer. Mr. Doherty is not a party to any current or proposed transaction with the Company for which disclosure is required under Item 404(a) of Regulation S-K.
    In connection with Mr. Doherty’s appointment, the Company’s Interim Chief Financial Officer, Megan Carlson, will be stepping down from serving in such capacity on the Effective Date, and will continue to serve as the Company’s Chief Accounting Officer and Senior Vice President of Finance & Accounting, as well as the Company’s principal accounting officer. On October 7, 2025, Ms. Carlson was also awarded a $200,000 cash retention bonus, which the Company shall pay to Ms. Carlson following December 31, 2026, provided that Ms. Carlson continuously remains employed with the Company through such date.
    John Doherty Offer Letter
    In connection with Mr. Doherty’s appointment as Executive Vice President, Chief Financial Officer, the Company entered into an offer letter (the “Offer Letter”) with Mr. Doherty. The Offer Letter provides for “at will” employment beginning on the Effective Date. Pursuant to the terms of his Offer Letter, Mr. Doherty is entitled to an annual base salary of $530,000. Mr. Doherty is also eligible for an annual cash bonus targeted at 70% of his base salary, effective beginning in 2027 with respect to performance in 2026. Mr. Doherty will receive a one-time sign-on bonus in the amount of $500,000, which is recoverable in full by the Company in the event that Mr. Doherty resigns without Good Reason (as defined in his Offer Letter) or the Company terminates Mr. Doherty’s employment for Cause (as defined in his Offer Letter) within six months of the commencement of his employment. Mr. Doherty will also receive a one-time 2025 performance bonus in the amount of $250,000, payable in the first quarter of 2026 at the same time other executives are awarded any bonuses for 2025 performance, which is recoverable in full by the Company in the event that Mr. Doherty resigns without Good Reason or the Company terminates Mr. Doherty’s employment for Cause within six months of Mr. Doherty’s receipt of such bonus.
    Pursuant to the terms of his Offer Letter and the Company’s Amended and Restated 2020 Equity Incentive Plan, Mr. Doherty will be granted, effective on the Effective Date, (i) restricted stock units (“RSUs”) relating to shares of the Company’s Class A Common Stock, par value $0.0001 per share (“Common Stock”) in an amount calculated by dividing $2,000,000 by the volume weighted average price of the Common Stock for the 10-day period ending the trading day prior to the date on which Mr. Doherty’s appointment as Executive Vice President, Chief Financial Officer of the Company was publicly announced (the “10-Day VWAP”), with one-third of such RSUs vesting on the first anniversary of the grant date and the remainder of such RSUs vesting on a pro rata annual basis over the next two years, and (ii) performance-based RSUs (“Performance RSUs”) in an amount calculated by dividing $1,000,000 by the 10-Day VWAP, with the Performance RSUs to vest as follows: (i) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $3.00 per share, (ii) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $4.50 per share and (iii) one-third shall vest upon the achievement of a price for the Common Stock equal to or exceeding $6.00 per share. For each Performance RSU vesting event to be achieved, the closing stock price for 20 consecutive trading days must equal or exceed the share price targets, and such share price must be achieved prior to the fifth anniversary of the grant date of such Performance RSU. The Performance RSUs are subject to acceleration in connection with a change in control of the Company in certain circumstances as set forth in the Offer Letter.



    Mr. Doherty is eligible to participate in the employee benefit plans generally available to full-time employees, subject to the terms of those plans. Mr. Doherty is also eligible for reimbursement of reasonable attorneys’ fees and costs incurred by him, up to $10,000, in connection with the drafting, review and negotiation of the Offer Letter and ancillary documents. Mr. Doherty will be entitled to benefits under the Company’s Executive Severance Plan as an executive vice president, including if the Company terminates Mr. Doherty’s employment without Cause or Mr. Doherty resigns for Good Reason.
    In connection with Mr. Doherty’s appointment, Mr. Doherty will enter into the Company’s standard form of indemnification agreement, a copy of which was filed as Exhibit 10.3 to the Company’s quarterly report on Form 10-Q for the three months ended June 30, 2025, filed with the Securities and Exchange Commission on August 1, 2025. Pursuant to the terms of the indemnification agreement, the Company may be required, among other things, to indemnify Mr. Doherty for some expenses, including attorneys’ fees, judgments, fines and settlement amounts incurred by him in any action or proceeding arising out of his service as one of our officers.
    The foregoing description of the Offer Letter with Mr. Doherty is qualified in its entirety by reference to the complete text of such agreement, which is filed as Exhibit 10.1 and is incorporated by reference herein.
    Item 7.01. Regulation FD Disclosure.
    On October 9, 2025, the Company issued a press release announcing the appointment of Mr. Doherty as Executive Vice President, Chief Financial Officer of the Company, a copy of which is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.
    The information in this Item 7.01, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
    Item 9.01 Financial Statements and Exhibits.
    (d)Exhibits.
    Exhibit No.Description
    10.1
    Offer Letter by and between Butterfly Network, Inc. and John Doherty, dated October 6, 2025
    99.1
    Press Release dated October 9, 2025
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    BUTTERFLY NETWORK, INC.
    By:/s/ Joseph M. DeVivo
    Name:Joseph M. DeVivo
    Title:Chief Executive Officer, President, and Chairman of the Board
    Date: October 9, 2025

    Get the next $BFLY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BFLY

    DatePrice TargetRatingAnalyst
    8/1/2025Outperform → Perform
    Oppenheimer
    7/1/2025$3.00Buy
    Craig Hallum
    3/17/2025Outperform
    William Blair
    9/10/2024$3.00Buy
    Lake Street
    3/29/2023$2.25Neutral
    UBS
    11/29/2022$4.50Outperform
    Oppenheimer
    10/4/2022$9.50Buy
    B. Riley Securities
    12/17/2021$7.00Neutral
    UBS
    More analyst ratings

    $BFLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Ku Victor was granted 847,930 shares (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    9/24/25 4:09:25 PM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form 3 filed by new insider Ku Victor

    3 - Butterfly Network, Inc. (0001804176) (Issuer)

    9/24/25 4:07:50 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Chief Business Officer Cashman Steve sold $214,313 worth of shares (142,590 units at $1.50), decreasing direct ownership by 6% to 2,181,884 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    9/8/25 4:57:27 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Butterfly Network downgraded by Oppenheimer

    Oppenheimer downgraded Butterfly Network from Outperform to Perform

    8/1/25 12:44:19 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Craig Hallum initiated coverage on Butterfly Network with a new price target

    Craig Hallum initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

    7/1/25 8:24:04 AM ET
    $BFLY
    Medical Electronics
    Health Care

    William Blair initiated coverage on Butterfly Network

    William Blair initiated coverage of Butterfly Network with a rating of Outperform

    3/17/25 7:23:53 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    SEC Filings

    View All

    Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Butterfly Network, Inc. (0001804176) (Filer)

    10/9/25 4:28:32 PM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form 10-Q filed by Butterfly Network Inc.

    10-Q - Butterfly Network, Inc. (0001804176) (Filer)

    8/1/25 4:28:38 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Butterfly Network, Inc. (0001804176) (Filer)

    8/1/25 7:53:36 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Business Officer Cashman Steve bought $81,953 worth of shares (50,000 units at $1.64), increasing direct ownership by 2% to 2,324,474 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    8/27/25 8:56:48 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $262,251 worth of shares (244,774 units at $1.07) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    9/4/24 4:34:48 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $1,683,373 worth of shares (1,676,869 units at $1.00) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    8/30/24 4:18:35 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Butterfly Network Appoints John Doherty as Chief Financial Officer

    Seasoned finance leader brings over 25 years of leadership experience driving growth and transformation Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the appointment of John Doherty as Executive Vice President, Chief Financial Officer, effective December 8, 2025. Doherty has more than 25 years of global financial leadership experience, guiding public and private companies through major growth, transformation, and strategic transactions across the technology and telecommunications industries. Doherty joins Butterfly from Kaltura, a global leader in video SaaS solut

    10/9/25 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Launches First-to-Market Artificial Intelligence Gestational Age Tool in Sub-Saharan Africa to Improve Maternal Health

    The new tool empowers lower skilled healthcare workers to quickly and accurately calculate gestational age, without needing image interpretation or training, to expand ultrasound access in under-resourced Sub-Saharan Africa Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the launch of a first-of-its-kind Gestational Age artificial intelligence (AI) tool in Malawi and Uganda. The tool is Butterfly's latest innovation to improve maternal and fetal health through AI-aided point-of-care ultrasound (POCUS), and comes as the Company announces a milestone year

    10/6/25 7:45:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Named to TIME's List of the World's Top HealthTech Companies 2025

    TIME honors Butterfly's role in advancing accessible diagnostic imaging Butterfly Network, Inc. ("Butterfly", "the Company") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced its inclusion in the first edition of the World's Top HealthTech Companies 2025, presented by TIME and Statista Inc., the world-leading statistics portal and industry ranking provider. The World's Top HealthTech Companies 2025 ranking recognizes leading innovators advancing healthcare globally through technology. Companies were evaluated using three primary data sources: Financial Performance Metrics, Reputation Analysis and Online Engagement. Out of thous

    9/18/25 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Leadership Updates

    Live Leadership Updates

    View All

    Butterfly Network Appoints John Doherty as Chief Financial Officer

    Seasoned finance leader brings over 25 years of leadership experience driving growth and transformation Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced the appointment of John Doherty as Executive Vice President, Chief Financial Officer, effective December 8, 2025. Doherty has more than 25 years of global financial leadership experience, guiding public and private companies through major growth, transformation, and strategic transactions across the technology and telecommunications industries. Doherty joins Butterfly from Kaltura, a global leader in video SaaS solut

    10/9/25 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints Victor Ku as Chief Technology Officer

    Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care through portable, semiconductor-based ultrasound technology and intuitive software, today announced the appointment of Victor Ku as Senior Vice President and Chief Technology Officer (CTO). Victor will join the company in late September and will be responsible for leading Butterfly's global technology strategy, product development, and innovation roadmap. "Victor's deep expertise in semiconductor-based imaging and his proven ability to scale global product development make him a perfect fit for Butterfly's next phase of growth," said Joseph DeVivo, President and CEO of Butterfly Network. "His leadership will b

    9/9/25 8:00:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints Steve Cashman as Chief Business Officer

    Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company's successful launch of its third-generation Butterfly iQ3 and historic revenue performance in the first half of 2024. Cashman will join Butterfly's Executive Management Team, overseeing the Company's global sales, marketing, product and corporate strategy. This press release f

    9/3/24 8:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Financials

    Live finance-specific insights

    View All

    Butterfly Network Reports Second Quarter 2025 Financial Results

    Delivered Highest Quarterly Revenue and Gross Margins in Company History  Quarterly Revenue of $23.4 million in Q2, representing 9% YoY growth, and Gross Margins of 64% Reduced quarterly Cash Used to $7.1 million, the lowest of any quarter Revised full year Revenue guidance and improved Adjusted EBITDA guidance Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the second quarter ended June 30, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chai

    8/1/25 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network to Report Second Quarter 2025 Financial Results on August 1, 2025

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report second quarter 2025 financial results on August 1, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 8:00 am ET on August 1 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations websi

    7/18/25 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network to Report First Quarter 2025 Financial Results on May 2, 2025

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report first quarter 2025 financial results on May 2, 2025 before the market opens. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast at 8:00 am ET on May 2 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Eve

    4/17/25 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    9/3/24 7:10:06 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    8/30/24 4:05:41 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by Butterfly Network Inc.

    SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

    7/8/24 4:32:42 PM ET
    $BFLY
    Medical Electronics
    Health Care